as a number of Cases of COVID-19 are increasing worldwide, and health authorities in the European Union have recommended the following: second booster vaccination for the elderly over 60.
The European Center is based in Stockholm for The Amsterdam-based European Medicines Agency (EMA) said the Prevention and Control of Diseases (ECDC) and the European Medicines Agency (EMA) second Supporter – Active Fourth – should It is considered for Those between the ages of 60 and 79, in addition to those with Putting them in pre-existing medical conditions risk of severe illness;
The two authorities have recommended a second booster for These are 80 and over in April. There is no time to lose, said Stella Kyriakides, EU Commissioner for Health and Food Safety. “I call on Member states to roll out second reinforcement for Everyone over the age of 60 as well as all vulnerable people immediately urged every qualified person to go out and vaccinate.”
“This is it how We protect ourselves, our loved ones and our vulnerable population.” added that at the moment “there is no clear Evidence support give second booster dose for people below 60 years of age who are not in higher risk of severe illness.”
health policy in European Union remains interrupt of individual member states, with Health in the European Union policy complementary serve national Policies. German Health Minister Karl Lauterbach welcomes the vaccination recommendation for people over 60. as for younger peopleTell public WDR radio, it will depend. In the case of younger people whoHowever, you have many contacts or who for For example, I have comorbidities, I will personally discuss the IV vaccination in Consultation with The attending physician said.
Israeli study on Fourth vaccinations and omicron variant in people in Nursing homes newly found Vaccine efficacy of 64% to 67% in terms of protection against hospitalization and 75% in terms of protection From death. the study in Data included in JAMA Internal Medicine on nearly 44,000 people. Fourth vaccinations reduce Hospitalization and mortality — it’s a lifesaver,” study co-author, Shetam Mohsen, told The Times of Israel.
